Patanase FDA Approval History
FDA Approved: Yes (First approved April 15, 2008)
Brand name: Patanase
Generic name: olopatadine hydrochloride
Dosage form: Nasal Spray
Company: Alcon, Inc.
Treatment for: Allergic Rhinitis
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.
Development Timeline for Patanase
|Apr 16, 2008||Alcon's Patanase Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms|
|Oct 11, 2007||Alcon Amends NDA for Patanase Nasal Spray|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.